Advances in Precision Diagnostics and Personalized Therapeutics for Prostate Cancer: An Integrated Precision Continuum from Risk-Adapted Detection to Biomarker-Directed Therapy and Dynamic Monitoring.

Noro T, Utsumi T, Ikeda R, Sugimoto T, Ishitsuka N, Kadono Y, Suzuki Y, Iijima S, Sugizaki Y, Somoto T, Oka R, Endo T, Kamiya N, Suzuki H.

Open source

DOI
10.3390/cancers18121909
Published
2026-06-11
Container
Cancers (Basel)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18121909,
  title = {Advances in Precision Diagnostics and Personalized Therapeutics for Prostate Cancer: An Integrated Precision Continuum from Risk-Adapted Detection to Biomarker-Directed Therapy and Dynamic Monitoring.},
  author = {Noro T and  Utsumi T and  Ikeda R and  Sugimoto T and  Ishitsuka N and  Kadono Y and  Suzuki Y and  Iijima S and  Sugizaki Y and  Somoto T and  Oka R and  Endo T and  Kamiya N and  Suzuki H.},
  year = {2026},
  journal = {Cancers (Basel)},
  doi = {10.3390/cancers18121909},
  url = {https://doi.org/10.3390/cancers18121909}
}

RIS

TY  - JOUR
TI  - Advances in Precision Diagnostics and Personalized Therapeutics for Prostate Cancer: An Integrated Precision Continuum from Risk-Adapted Detection to Biomarker-Directed Therapy and Dynamic Monitoring.
AU  - Noro T
AU  -  Utsumi T
AU  -  Ikeda R
AU  -  Sugimoto T
AU  -  Ishitsuka N
AU  -  Kadono Y
AU  -  Suzuki Y
AU  -  Iijima S
AU  -  Sugizaki Y
AU  -  Somoto T
AU  -  Oka R
AU  -  Endo T
AU  -  Kamiya N
AU  -  Suzuki H.
PY  - 2026
JO  - Cancers (Basel)
DO  - 10.3390/cancers18121909
UR  - https://doi.org/10.3390/cancers18121909
ER  - 

APA

T, N., T, U., R, I., T, S., N, I., Y, K., Y, S., S, I., Y, S., T, S., R, O., T, E., N, K., & H., S. (2026). Advances in Precision Diagnostics and Personalized Therapeutics for Prostate Cancer: An Integrated Precision Continuum from Risk-Adapted Detection to Biomarker-Directed Therapy and Dynamic Monitoring.. Cancers (Basel). https://doi.org/10.3390/cancers18121909

Source records